keyword
MENU ▼
Read by QxMD icon Read
search

Bioresorbable scaffold

keyword
https://www.readbyqxmd.com/read/28935086/coronary-artery-aneurysm-with-thrombosis-after-implantation-of-a-bioresorbable-coronary-artery-scaffold
#1
Rayyan Hemetsberger, Osman Gürocak, Mohamad Soud, Hector M Garcia-Garcia, Joachim Weber-Albers, Holger Nef, Helge Möllmann
No abstract text is available yet for this article.
September 25, 2017: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/28935085/early-collapse-of-a-magnesium%C3%A2-bioresorbable-scaffold
#2
Hector Cubero-Gallego, Bert Vandeloo, Josep Gomez-Lara, Rafael Romaguera, Gerard Roura, Joan A Gomez-Hospital, Angel Cequier
No abstract text is available yet for this article.
September 25, 2017: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/28935082/bioresorbable-vascular-scaffolds-in%C3%A2-women
#3
EDITORIAL
Gennaro Giustino, George D Dangas
No abstract text is available yet for this article.
September 25, 2017: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/28935081/efficacy-and-safety-of-the-absorb-bioresorbable-vascular-scaffold-in-females-and-males-results-of-an-individual-patient-level-pooled-meta-analysis-of-randomized-controlled-trials
#4
Satya Shreenivas, Dean J Kereiakes, Stephen G Ellis, Runlin Gao, Takeshi Kimura, Yoshinobu Onuma, Karine Piard-Ruster, Yunlong Zhang, Kai Koo, Minh-Thien Vu, Patrick W Serruys, Gregg W Stone
OBJECTIVES: Because females are under-represented in coronary trials, this study sought to assess the relative safety and efficacy of Absorb bioresorbable vascular scaffold (BVS) (Abbott Vascular, Santa Clara, California) and the Xience everolimus-eluting stent in females compared with males. BACKGROUND: The Absorb everolimus-eluting BVS provides drug delivery and mechanical support similar to a metallic drug-eluting stent, followed by resorption and restoration of more normal vascular structure with the potential to improve late clinical outcomes...
September 25, 2017: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/28935079/effect-of-post-dilatation-following-primary-pci-with-everolimus-eluting-bioresorbable-scaffold-versus-everolimus-eluting-metallic-stent-implantation-an-angiographic-and-optical-coherence-tomography-trofi%C3%A2-ii%C3%A2-substudy
#5
Kyohei Yamaji, Salvatore Brugaletta, Manel Sabaté, Andrés Iñiguez, Lisette Okkels Jensen, Angel Cequier, Sjoerd H Hofma, Evald Høj Christiansen, Maarten Suttorp, Gerrit Anne van Es, Yohei Sotomi, Yoshinobu Onuma, Patrick W Serruys, Stephan Windecker, Lorenz Räber
OBJECTIVES: This study sought to investigate the effect of post-dilatation on angiographic and intracoronary imaging parameters in the setting of primary percutaneous coronary intervention comparing the everolimus-eluting bioresorbable scaffold (BRS) with the everolimus-eluting metallic stent (EES). BACKGROUND: Routine post-dilatation of BRS has been suggested to improve post-procedural angiographic and subsequent device-related clinical outcomes. METHODS: In the ABSORB STEMI TROFI II trial, 191 patients with ST-segment elevation myocardial infarction were randomly assigned to treatment with BRS (n = 95) or EES (n = 96)...
September 25, 2017: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/28935078/bioresorbable-vascular-scaffold-implantation-to-whom-and-how
#6
EDITORIAL
Manel Sabaté
No abstract text is available yet for this article.
September 25, 2017: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/28935077/a-prospective-evaluation-of-a-pre-specified-absorb-bvs-implantation-strategy-in-st-segment-elevation-myocardial-infarction-the-bvs-stemi-strategy-it-study
#7
Alfonso Ielasi, Gianluca Campo, Claudio Rapetto, Attilio Varricchio, Bernardo Cortese, Salvatore Brugaletta, Salvatore Geraci, Paolo Vicinelli, Fortunato Scotto di Uccio, Gioel Gabrio Secco, Arnaldo Poli, Elisa Nicolini, Kohki Ishida, Azeem Latib, Maurizio Tespili
OBJECTIVES: The aim of this study was to assess the feasibility and clinical results following a pre-specified bioresorbable scaffold (Absorb BVS) implantation strategy in patients with ST-segment elevation myocardial infarction (STEMI). BACKGROUND: Concerns were raised about the safety of Absorb because a non-negligible rate of thrombosis was reported within 30 days and at midterm follow-up after primary percutaneous coronary intervention. METHODS: This was a prospective, multicenter study of patients with STEMI (<75 years of age with symptom onset <12 h) undergoing primary percutaneous coronary intervention with Absorb following a dedicated implantation protocol...
September 25, 2017: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/28935076/fantom-bioresorbable-scaffold-verse-but-not-yet-chorus-an-incomplete-composition
#8
EDITORIAL
Stephen G Ellis
No abstract text is available yet for this article.
September 25, 2017: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/28935075/6-month-clinical-and-angiographic-outcomes-of-a-novel-radiopaque-sirolimus-eluting-bioresorbable-vascular-scaffold-the-fantom-ii-study
#9
Alexandre Abizaid, Didier Carrié, Norbert Frey, Matthias Lutz, Joachim Weber-Albers, Darius Dudek, Bernard Chevalier, Shu-Chuan Weng, Ricardo A Costa, Jeffrey Anderson, Gregg W Stone
OBJECTIVES: The purpose of this study was to evaluate the outcomes of the novel Fantom coronary bioresorbable scaffold at 6 months. BACKGROUND: The Fantom sirolimus-eluting bioresorbable scaffold incorporates a unique proprietary iodinated, polycarbonate copolymer of tyrosine analogs that is radiopaque, with thin struts (125 μm) that facilitate device delivery and precise target lesion treatment. METHODS: The 6-month outcomes and performance of the Fantom scaffold were evaluated in 117 patients with single de novo native coronary artery lesions of length ≤20 mm and reference vessel diameter 2...
September 25, 2017: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/28935074/bioresorbable-vascular-scaffolds%C3%A2-restenosis-pathophysiology-and-predictors
#10
EDITORIAL
Fernando Alfonso, Javier Cuesta
No abstract text is available yet for this article.
September 25, 2017: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/28935073/incidence-clinical-presentation-and-predictors-of-clinical-restenosis-in-coronary-bioresorbable-scaffolds
#11
Alberto Polimeni, Melissa Weissner, Katharina Schochlow, Helen Ullrich, Ciro Indolfi, Jouke Dijkstra, Remzi Anadol, Thomas Münzel, Tommaso Gori
OBJECTIVES: The aim of this study was to describe the incidence and clinical characteristics, including intracoronary imaging features, of clinical restenosis in bioresorbable coronary scaffolds (BRS). Further, the authors searched for clinical and procedural predictors of scaffold restenosis (ScR) and report on the clinical outcomes after treatment of ScR in a cohort of consecutive all-comer patients. BACKGROUND: Data from randomized controlled trials demonstrate a higher rate of target lesion failure in patients treated with BRS as compared with those treated with metal drug-eluting stents...
September 25, 2017: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/28935072/bioresorbable-vascular-scaffold-thrombosis-solutions-to-the-problem
#12
EDITORIAL
Michael A Kutcher
No abstract text is available yet for this article.
September 25, 2017: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/28935071/clinical-angiographic-and-procedural-correlates-of-acute-subacute-and-late-absorb-scaffold-thrombosis
#13
Stephen G Ellis, Giuseppe Steffenino, Dean J Kereiakes, Gregg W Stone, R J van Geuns, Alexandre Abizaid, Holger Nef, Bernardo Cortese, Luca Testa, Maurizio Menichelli, Corrado Tamburino, Tommaso Gori, Takeshi Kimura, Patrick W Serruys, Salvatore Brugaletta, Manel Sabaté, Run-Lin Gao
OBJECTIVES: The authors sought to identify and verify independent correlates of device thrombosis from an analysis of multicenter trials and registries. BACKGROUND: Recent analyses suggest an increased risk of device thrombosis with Absorb bioresorbable vascular scaffold (Abbott Vascular, Santa Clara, California) implantation compared with metallic drug-eluting stents, and data from moderate size studies suggest a risk relationship to vessel size and technique. METHODS: From 8,771 consecutively treated patients, 105 patients (1...
September 25, 2017: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/28932531/adverse-events-with-bioresorbable-vascular-scaffolds-in-routine-percutaneous-coronary-interventions-coup-de-th%C3%A3-%C3%A3-tre-or-unfinished-play
#14
EDITORIAL
Salvatore Cassese, Oliver Husser, Adnan Kastrati
No abstract text is available yet for this article.
August 2017: Journal of Thoracic Disease
https://www.readbyqxmd.com/read/28932529/bioresorbable-scaffolds-versus-metallic-stents-in-routine-pci-the-plot-thickens
#15
EDITORIAL
Athanasios Katsikis, Patrick W Serruys
No abstract text is available yet for this article.
August 2017: Journal of Thoracic Disease
https://www.readbyqxmd.com/read/28932528/first-generation-bioresorbable-vascular-scaffolds-do-they-hold-the-promise
#16
EDITORIAL
Islam Y Elgendy, Ahmed N Mahmoud, R David Anderson
No abstract text is available yet for this article.
August 2017: Journal of Thoracic Disease
https://www.readbyqxmd.com/read/28932360/very-late-bioresorbable-scaffold-thrombosis-and-reoccurrence-of-dissection-two-years-later-chronic-total-occlusion-recanalization-of-the-left-anterior-descending-artery
#17
Luigi Di Serafino, Plinio Cirillo, Tullio Niglio, Francesco Borgia, Bruno Trimarco, Giovanni Esposito, Eugenio Stabile
We describe the case of a patient presenting with ST-segment elevation myocardial infarction due to very late scaffold thrombosis. The patient was already admitted for an elective percutaneous recanalization of a chronically occluded left anterior descending artery (LAD). The procedure was performed according the sub-intimal tracking and re-entry (STAR) technique with 4 bioresorbable vascular scaffolds implantation. However, even though the coronary flow was preserved at the end of the procedure, the dissected segment was only partially sealed at the distal segment of the LAD...
August 26, 2017: World Journal of Cardiology
https://www.readbyqxmd.com/read/28930077/bioresorbable-vascular-scaffold-in-chronic-total-occlusions
#18
Jiang Ming Fam, Roberto Diletti
No abstract text is available yet for this article.
September 20, 2017: EuroIntervention
https://www.readbyqxmd.com/read/28930076/bioresorbable-vascular-scaffold-in-chronic-total-occlusions
#19
Antoine Gerbay, Karl Isaaz
No abstract text is available yet for this article.
September 20, 2017: EuroIntervention
https://www.readbyqxmd.com/read/28930075/bioresorbable-scaffolds-reflections-after-a-setback-losing-a-battle-does-not-mean-losing-the-war
#20
Antonio Colombo, Lorenzo Azzalini
No abstract text is available yet for this article.
September 20, 2017: EuroIntervention
keyword
keyword
52455
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"